Exploring Growth and Emerging Trends in the Microfluidic Immunoassay Market: Inn

1. Microfluidic Immunoassay Market to be Worth $1.59 Billion by 2031

2. Global Microfluidic Immunoassay Market – 2023-2030 A recent publication from Meticulous Research® estimates that the global microfluidic immunoassay market will grow at a CAGR of 7.3%, reaching $1.59 billion by 2031. In recent years, the landscape of clinical diagnostics has been reshaped by the rising demand for real-time detection, spurred by the increasing incidence of chronic and infectious diseases. This surge in demand has driven the need for highly sensitive, rapid, and portable immunoassay methods that offer enhanced accuracy. Microfluidic technology, when integrated with immunoassays, is playing a pivotal role in overcoming the limitations of conventional diagnostic methods, both in research and clinical settings. By miniaturizing laboratory functions onto a chip, microfluidic immunoassay systems eliminate the need for extensive sample preparation, bulky laboratory equipment, and highly specialized personnel, offering significant advantages in resource-limited environments where portability and speed are crucial. Download Sample Report Here @ https://www.meticulousresearch.com/download- sample-report/cp_id=5034 Rise of Multiplexed Panel Detection A key trend in the microfluidic immunoassay market is the increasing adoption of multiplexed panel detection. Detecting a single molecular event is often insufficient to fully understand the complex pathophysiology of diseases like cancer, which necessitates multianalyte-based diagnostic tests. Relying on a single biomarker for early diagnosis often falls short in capturing the full complexity of conditions like cancer. This has sparked a growing demand for diagnostic tools that can simultaneously detect multiple biomarkers. Multiplexed diagnostic testing, powered by microfluidic technology, offers several advantages, such as the simultaneous detection of multiple analytes, improved sensitivity, faster reaction times, and reduced reagent consumption. The spatial precision enabled by microfluidic systems allows for the immobilization of proteins and biomolecules within microchannels, facilitating multiparameter assays in a single test. This trend toward multiplexed detection has gained momentum, with various companies expanding their lab-on-a-chip (LOC) solutions to offer multi- analyte diagnostics. In particular, point-of-care (POC) multi-analyte testing for infectious diseases is becoming increasingly valuable, allowing for rapid diagnosis and timely treatment decisions. In contrast, traditional diagnostic methods, which often rely on culturing samples and single-analyte tests, can delay diagnosis, leading to severe consequences such as septic shock or even death. Browse immunoassay-market-5034 in Depth @ https://www.meticulousresearch.com/product/microfluidic- Cardiology and Microfluidic Immunoassays The application of microfluidic immunoassays in cardiology has proven particularly beneficial. Cardiovascular diseases, responsible for approximately 17.1% of deaths in the U.S., require swift diagnosis and intervention, particularly in resource-limited settings. Microfluidic cartridges are Page 1 of 3 © Meticulous Research| sales@meticulousresearch.com

3. Global Microfluidic Immunoassay Market – 2023-2030 well-suited for detecting cardiac biomarkers—proteins released into the bloodstream following heart muscle damage—which are crucial for diagnosing conditions like myocardial infarction. Leading companies like Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Micropoint Biotechnologies (China), and QuidelOrtho Corporation (U.S.) are spearheading advancements in this area. These firms are developing microfluidic cartridges capable of detecting a variety of cardiac biomarkers, including Troponin, CK-MB, D-Dimer, CRP, and myoglobin, enabling quick and accurate diagnosis of heart-related conditions. Current research is focused on multiplexed assays that can detect several cardiac conditions simultaneously, requiring minimal sample volume and reducing the time to diagnosis. Market Insights and Future Growth According to Meticulous Research®, the microfluidic immunoassay market is projected to reach $1.59 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.3% between 2024 and 2031. The market’s growth is driven by continuous innovations in research and development, including the miniaturization of assays, automation, and the rise of multiplexed detection systems. Key trends in the market include the increasing portability of detection devices and cartridges, advancements in fabrication technologies, and improvements in R&D processes aimed at enhancing patient outcomes. North America is expected to dominate the global microfluidic immunoassay market by 2024, largely due to the presence of leading players such as Becton, Dickinson and Company (U.S.), Revvity, Inc. (U.S.), Abbott Laboratories (U.S.), and QuidelOrtho Corporation (U.S.). These companies have established strong footholds in multiple regions, driving the widespread adoption of their innovative microfluidic solutions. The market is poised for further growth as new technologies and applications continue to emerge. Buy Now@https://www.meticulousresearch.com/Checkout/80588586 Key questions answered in the report: • Which are the high-growth market segments in terms of product, technology, application, end user, and regions/countries? • What was the historical market for microfluidic immunoassay across the globe? • What are the market forecasts and estimates for the period 2024–2031? • What are the major drivers, restraints, challenges, opportunities, and trends in the global microfluidic immunoassay market? • Who are the major players in the global microfluidic immunoassay market? • What is the competitive landscape, and who are the market leaders in the global microfluidic immunoassay market? • What are the recent developments in the microfluidic immunoassay market? Page 2 of 3 © Meticulous Research| sales@meticulousresearch.com

4. Global Microfluidic Immunoassay Market – 2023-2030 • What are the different strategies adopted by the major players in the microfluidic immunoassay market? • What are the geographical trends and high-growth regions/countries? Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 3 of 3 © Meticulous Research| sales@meticulousresearch.com